Health Care Equipment & Services

UHS insider moves reveal family trust re‑allocations with no market impact, highlighting stability but no fresh capital for growth.

Insider buying surge at Streamex Corp. signals bullish momentum—understand why the chairman’s disciplined purchases and GLDY token platform could boost stock value.

JW Asset Management’s recent sell‑off of 25,320 ELHC shares reveals a deliberate portfolio rebalancing amid a 112 % year‑to‑date rally, signaling strategic profit‑realisation and potential supply pressure while underscoring ELHC’s solid growth funda…

Tenet Healthcare insider buys 1,188 RSUs on May 27, showing board’s long‑term confidence and a value‑seeking opportunity as the stock trades near a 52‑week low.

CEO Bailey David F’s latest insider buying at $5.59‑$5.79 on a stock down 99% signals cautious confidence in a volatile market, urging investors to weigh future growth plans.

Explore how Clover Health insider sales reveal portfolio strategy—not a warning—while evaluating the company’s upside and risk.

Guardant Health’s chief legal officer sells 10,000 shares at $125.08—a disciplined portfolio move that signals confidence in the stock’s upcoming rally.

Ronda E. Stryker’s May 2026 sale shows a calculated portfolio shift, not a warning, amid Stryker’s strong product pipeline and steady upside potential.

Medtronic insider buying signals confidence amid a market slump. Learn why executives are buying shares and what it means for investors.

Insider buying at Cencora shows confidence, not panic—Durcan Dermot Mark’s 4,000‑share purchase signals long‑term conviction and potential upside.